NYSE:PG

Procter & Gamble (PG)

145.10
-1.44 (0.98%)
as of Jun 8, 2026, 8:00:00 pm Market Open.
239 watching
0
Investor Insights
star iconJun 7, 2026, 12:00 am

This summary was created by AI, based on 12 opinions in the last 12 months.

Experts express a cautionary view on Procter & Gamble (PG), highlighting challenges in the consumer sector amid rising input costs and economic uncertainties. While the company remains a reputable dividend aristocrat with a near 3% yield, many analysts are hesitant due to its recent 14.4% decline over the past year and the expectation of modest growth, which is around 4.5%. Despite these challenges, some experts view PG's robust brand portfolio as a strength, indicating that the stock may bounce back in the long term due to its defensive nature amid potential economic downturns. There is a sentiment that PG may be a solid buy as it trades at an attractive valuation, although considerable risks remain in the consumer staples sector, leading to a mixed outlook for substantial returns.

consensus icon
Consensus
Neutral
valuation icon
Valuation
Undervalued
review icon
Similar
Nestle, NESN
BUY ON WEAKNESS
PG vs JNJ He'd choose PG. JNJ has lawsuits still hanging around. Since mid-summer of 2018, JNJ has underperformed PG. Watch out for valuations. PG is trading at 24x, with a 7% growth rate. PG is the largest consumer name out there and will continue to grow.
HOLD
It has done so much better than he would have thought. The market is looking for safe investments; companies that don't disappoint. He would not buy here. There is nothing wrong with the name. (Analysts’ price target is $127.00)
DON'T BUY
[Is this a good time to get in and will it give protection against markets going down?] Many of these have boosted their price with a higher dividend. When you look at the multiple it tends to be at the high end of the historical range and that represents a danger signal to him. They are growing their revenues slow singe digits. (Analysts’ price target is $122.09)
DON'T BUY
It has had a great move up this year -- up 46%. He struggles with it as it is in a slow growth space. You are paying over 20 times earnings and growth is maybe around 10%. (Analysts’ price target is $104.00)
BUY ON WEAKNESS
It's still in turnaround. His target is $93.83. Buy at $81.
BUY
One of the better names one as it is trading at a discount.
DON'T BUY
They try to manage their P&L well to earn a 7-9% earnings growth rate and the yields have competed well against bonds. He is hesitant on this space, because society has evolved away from buying branded products that can be 50% more expensive.
DON'T BUY

Consumer staples stocks grew on a search for yield. But the problem is the stock price will fall, which is what's happening now as interest rates rise. The lure of yield stocks is not as strong anymore.

DON'T BUY

Consumer staples stocks have been under a lot of pressure because of who they sell to (buyers are putting pricing pressure on them) and competition from start-up local brands. This is pressuring their margins. She has not owned P&G for years. Back then, innovation flowed through the company (more so than now). They are in beauty care, which she likes, but they have to do more product innovation. The company is trying to do that, but not enough. In this space, she would invest in Mondelez (MDLZ-O) or Unilever PLC (UL-N) because of their exposure to emerging markets.

WEAK BUY

This is down about 15% this year. From an entry perspective, it is looking more attractive; however, the P/E is still around 19 times. The yield is also supportive. The company has been focusing back to its core brands and this will take time. He would price in some further downside, but sees this as a time to step into 1/3 of your target holding. Yield 3.5%.

DON'T BUY

A classic consumer growth stock that's struggling now. Today, Facebook and Google are better companies which have the same PE. PG has used all its levers, including buying back stock. Its debt equity ratio has risen. He doesn't own this sector which is out of favour globally. PG is also hurt by the shift in U.S. retail.

WATCH

This good company has done poorly as of late as investors are looking for growth stocks in fear of higher interest rates. Seasonally consumer staples do well this time of year. He is waiting to see if the US 10 year yield retraces as this stock could be a very good buy. The stock is substantially under-performing the market right now. He would wait until it shows strength again seasonally in August.

WATCH

From June to October is the right period to buy this. Defensive name. Longer term momentum is not on its side. It is trading a down channel. MSCD is positive diverting. Selling pressure is waning. If you see it go over 75 might be an opportunity to buy.

COMMENT

The group has sold off a but due to a lack of innovation and more competition; it's easier than for e-companies to sell directly to consumers. There needs to be more pricing flexbility given they compete with the Amazons of the world. They're in a margin squeeze. An investor needs exposure in this space. P&G sells defensive products (i.e. lotions) that consumers use daily, but she prefers Unilever given their exposure to emerging markets.

DON'T BUY

This company needs a shake-up he thinks. An activist investor is now on the Board so this may help. His fair market model value is $81.35. There is better value elsewhere at this time.

Showing 76 to 90 of 234 entries